James M. Chen

Antiviral phosphonate analogs

Antiviral phosphonate analogs

ANTIVIRAL PHOSPHONATE ANALOGS

Nucleoside Phosphonate Analogs

Nucleoside analogs for antiviral treatment

ANTI-CANCER PHOSPHONATE ANALOGS

ANTIVIRAL PROTEASE INHIBITORS

Antiviral phosphonate analogs

PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY

KINASE INHIBITORY PHOSPHONATE ANALOGS

PHOSPHONATE ANALOGS FOR TREATING METABOLIC DISEASES

Antiviral protease inhibitors

AZA-peptide protease inhibitors

Pre-organized tricyclic integrase inhibitor compounds

Phosphonate inhibitors of HCV

Method and compositions for identifying anti-hiv therapeutic compounds

Pre-organized tricyclic integrase inhibitor compounds

Purine nucleoside phosphorylase inhibitory phosphonate compounds

Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds

Therapeutic phosphonate compounds

Pre-organized tricyclic integrase inhibitor compounds

Non nucleoside reverse transcriptase inhibitors

Method and compositions for identifying anti-hiv therapeutic compounds

Anti-cancer phosphonate analogs

Phosphonate compounds having immuno-modulatory activity

Kinase inhibitory phosphonate analogs

Nucleoside phosphonate analogs

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

Method and compositions for identifying anti-HIV therapeutic compounds

Phosphonate analogs for treating metabolic diseases

Antiviral phosphonate analogs

Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds

Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors

Non nucleoside reverse transcriptase inhibitors